This country profile provides an overview of Togo’s progress in reaching those in need of mass NTD treatment based on 2019 data.
*This includes all countries in Africa that are endemic for at least one of the five NTDs
Treatment coverage
Elephantiasis
N/A
Blinding trachoma
100%
Intestinal worms
99%
Bilharzia
34%
River blindness
83%
4.28 million
people received treatment in Togo in 2019
30k
people did not receive treatment in Togo in 2019
Elephantiasis
Togo has eliminated elephantiasis as a public health problem.
Blinding trachoma
Togo claims to have eliminated blinding trachoma as a public health problem.
Intestinal worms
Treatment coverage increased from 84% in 2018 to 99% in 2019.
Pre-sch and school-aged children needing treatment
2.39m
Pre-school and school-aged children receiving treatment
2.36m
Bilharzia
Treatment coverage decreased from 100% in 2018 to 34% in 2019.
School-aged children needing treatment
1.2m
School-aged children receiving treatment
408k
River blindness
Treatment coverage decreased from 84% in 2018 to 83% in 2019.
People needing treatment
3.69m
People receiving treatment
3.07m
The 
ESPEN portal (a World Health Organization AFRO region project) provides maps and district-level data for the preventive chemotherapy diseases in Togo.